EP1730169A2 - Metallhaltige nanoschichtverbundwerkstoffe und anwendungen davon - Google Patents

Metallhaltige nanoschichtverbundwerkstoffe und anwendungen davon

Info

Publication number
EP1730169A2
EP1730169A2 EP04821785A EP04821785A EP1730169A2 EP 1730169 A2 EP1730169 A2 EP 1730169A2 EP 04821785 A EP04821785 A EP 04821785A EP 04821785 A EP04821785 A EP 04821785A EP 1730169 A2 EP1730169 A2 EP 1730169A2
Authority
EP
European Patent Office
Prior art keywords
metal
ngcgn
helical sequence
sequence
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP04821785A
Other languages
English (en)
French (fr)
Inventor
Regina Valluzzi
Terry E. Haas
Robert P. Guertin
Jia Huang
Hyoung-Joon Jin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tufts University
Original Assignee
Tufts University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tufts University filed Critical Tufts University
Publication of EP1730169A2 publication Critical patent/EP1730169A2/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0056—Peptides, proteins, polyamino acids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C07K14/43586—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from silkworms

Definitions

  • a third approach can be envisioned in which peptide chemical templates attach inorganics (or nucleate and orient crystals) while the shape and interactions of the peptide molecules pattern the size and shape of the inorganic domains, order to achieve this level of control, needed are asymmetric peptide structures with a strong "built- in" driving force to associate in a predictable geometry.
  • the fibrous linear proteins found in naturally occurring materials, such as collagen, silk or keratin can serve as guides to synthesizing potentially useful strong linear organic molecular materials.
  • Using techniques of modern biotechnology and inspired by these biologically active materials several linear chain-like oligopeptide molecules have been developed. These ohgopeptides tend to self-assemble and form smectic liquid crystal-like configurations in solution.
  • the system is unstable to spontaneous magnetic order below about 20 K.
  • the 3D order of these transition metal-based systems can be either antiferro- or ferro-magnetic depending on the spacing.
  • rare earth ions can have very high spins making them valuable in high spin magnetic materials, and they may also find application in nanomagnetic materials.
  • Approaches to molecular magnets have relied heavily on organometallic chemistry to produce complex molecules representing unique spin systems. Intermolecular coupling is largely dependent on getting these complex molecules into a crystal or other ordered arrangement. It is believed that the type of coupling depends on the geometric and electronic structure of the crystal.
  • the present invention relates to an ordered biopolymeric material comprising rod-shaped polypeptides comprising a self-fabricating helical sequence, a sequence comprising functional groups at the N-terminus, C-terminus, or at both termini of the polypeptides, and a metal, wherein the metal coordinates to the functional groups, and wherein the rod-shaped polypeptides self orient into a series of layers wherein the axes of the rod-shaped polypeptides are perpendicular to the plane of the layers.
  • the fibrous protein is selected from the group consisting of silk, collagens, keratins, actins, and chorions. In a further embodiment, the fibrous protein is silk.
  • the self-fabricating helical sequence of the ordered biopolymeric material comprises alanine, glycine, proline, or serine, or a combination thereof.
  • the sequence comprising functional groups at the N- terminus, C-terminus, or at both termini of the polypeptides comprises amino acids selected from the group consisting of glutamic acid, lysine, histidine, cysteine, and asparagine.
  • the metal of the ordered biopolymeric material of the present invention is a rare-earth metal.
  • the metal is Gd, Dy, Pr,
  • the ordered biopolymeric material of the present invention further comprises a metal in the interlamellar spacing of the ordered biopolymeric material.
  • the metal is a transition metal. In a further embodiment, the transition metal is a second row transition metal. In a further embodiment, the transition metal is a third row transition metal. In a further embodiment, the metal is selected from the group consisting of Cr, Mo, Co, Ni, Cu, Fe, Hg, Au, Ta, W, Pt, Ag, Pd, and mixtures thereof. In a further embodiment, the ordered biopolymeric material of the present invention further comprises a metalloid. In a further embodiment, the metalloid is Si, Ge or a mixture thereof. ⁇ In a further embodiment, the self-fabricating helical sequence and the sequence comprising functional groups, combined, comprises one of the following sequences:
  • the ordered biopolymeric material of the present invention comprises layers of rod-shaped polypeptides of about 10 nm or less. In a further embodiment, the layers are about 5 nm or less. In a further embodiment, the layers are about 1 nm or less.
  • the present invention relates to a method of preparing the ordered biopolymeric material of the present invention, comprising: a) preparing an aqueous solution of lyophilized oligopeptide powders; b) adding the metal to the aqueous solution of step a); c) optionally agitating the mixture from step b); d) optionally heating the mixture from step b) or c); I e) allowing the mixture from step b), c), or d) to stand for about 1 hour to about 24 hours; f) separating any suspended metal from the mixture of step e); and g) allowing the resulting solution from step f) to dry.
  • the metal in the method of preparing an ordered biopolymeric material of the present invention is a rare-earth metal and is in the form of a powdered oxide.
  • the metal is a rare-earth metal and is in the form of a chloride in a dilute HCl solution.
  • the present invention relates to a method of preparing a structured peptide-metal-complexed material, comprising: a) combining a peptide that is amphiphihc or rigid or both that contains a metal- binding group with a metal to give a mixture; b) removing a portion of the solvent from the mixture to generate a liquid crystalline material; c) adjusting the temperature of the liquid crystalline material; and d) removing a portion of solvent from the liquid crystalline material.
  • the peptide comprises a sequence selected from the group consisting of : E 3 (GAGAGS) 4 E 3 , E 5 (GAGAGS) 4 E 5 , E 6 (GAGAGS) 4 E 6 , E 3 (GSPGPP) 6 E 3 , E 5 (GSPGPP) 6 E 5 , E 6 (GSPGPP) 6 E 6 , E 2 (GAGAGS) ( i.
  • the metal is a rare-earth metal. In a further embodiment, the metal is Gd, Dy, Pr, Cs, Er, Ho, or a mixture thereof. In a further embodiment, the metal is Gd, Dy, or a mixture thereof. In a further embodiment, the metal is a transition metal. In a further embodiment, the metal is a first row transition metal, hi a further embodiment, the metal is a second row transition metal. In a further embodiment, the metal is a third row transition metal, hi a further embodiment, the metal is a transition metal selected from the group consisting of Cr, Mo, Co, Ni, Cu, Au, Fe, Hg, Ta, W, Pt, Ag, Pd, and mixtures thereof.
  • the metal is a transition metal in the form of a complex selected from the group consisting of: anionic polyoxometallates, polynuclear cationic species, and chiral complexes.
  • anionic polyoxometallates are selected from the group consisting of: isopolymolybdates, heteropolymolybdates, isopolytungstates, and heteropolytungstates;
  • the polynuclear cationic species are selected from the group consisting of Ta 6 Cl 12 2+ , Ta 6 Br ⁇ 2 2+ , 6 C1 8 4+ , and W 6 Br 8 4+ ;
  • the chiral complexes are selected from the group consisting of tris- bipyridylruthenium(II) and tris(tetramminedihydroxocobalt( ⁇ i))cobalt(II ⁇ ) cation.
  • the present invention relates to an ordered biopolymeric material, comprising a rod-shaped polypeptide that comprises a self-fabricating helical sequence, wherein the self-fabricating helical sequence is selected from the group consisting of: EEEAAAKEEE, EECCAKEECE, EEEGAGAGSEEE, NNECACKCCNE, EAAKEAAAK, CCEAAAKDAAHC, and HCAAEAAAKCH; and wherein the rod-shaped polypeptide is a component of a layer, wherein the axis of the rod-shaped polypeptide is perpendicular to the plane of the layer.
  • the present invention relates to a peptide sequence selected from the group consisting of: EEEAAAKEEE, EECCAKEECE, EEEGAGAGSEEE, NNECACKCCNE, EAAKEAAAK, CCEAAAKDAAHC, and HCAAEAAAKCH.
  • the present invention relates to a polymer comprising a peptide sequence selected from the group consisting of: EEEAAAKEEE, EECCAKEECE, EEEGAGAGSEEE, NNECACKCCNE, EAAKEAAAK, CCEAAAKDAAHC, and HCAAEAAAKCH.
  • the present invention relates to a rod-shaped polypeptide that comprises a self-fabricating helical sequence and a metal-binding group at the N- terminus or C-terminus or both, wherein the self-fabricating helical sequence is selected from the group consisting of: E 3 (GAGAGS) 4 E 3 , E 5 (GAGAGS) 4 E 5 , E 6 (GAGAGS) 4 E 6 , E 3 (GSPGPP) 6 E 3 , E 5 (GSPGPP) 6 E 5 , E 6 (GSPGPP) 6 E 6 , E 2 (GAGAGS) (1 . 6) E 4 , E 4 (GAGAGS) (1 .
  • the present invention relates to a film comprising the ordered biopolymeric material of the present invention.
  • the present invention relates to a magnet, comprising the ordered biopolymeric material of the present invention, wherein the magnet is paramagnetic, aniferromagnetic, spinglass, superparamagnetic, ferromagnetic, ferrimagnetic, or antiferrimagnetic.
  • the present invention relates to a magnet comprising an ordered biopolymeric material, wherein the magnet is pressure sensitive, and wherein the magnet is paramagnetic, aniferromagnetic, spinglass, superparamagnetic, ferromagnetic, ferrimagnetic, or antiferrimagnetic.
  • Figure 1 depicts (a): Illustration of the chemically distinct regions in the oligopeptide molecular sequences, (b): schematic illustration of the long-range order layered structure, which is like a smectic liquid crystal. The layered domains are specified in the molecular sequence.
  • Figure 2 depicts (a): TEM micrograph of a self-assembled silk-like oligopeptide, E 5 (GAGAGS) E 5 , with a ⁇ 4 nm layered structure showing patterning due to smectically arrayed linear molecules, (b): Field emission SEM micrograph of a 10 nm collagen-like layered oligopeptide.
  • Figure 3 depicts polycrystalline X-ray diffraction texture from oligopeptide samples and rare earth complexed oligopeptide nanocomposites.
  • Figure 4 depicts integrated intensity traces
  • Chloride complexed oligopeptide nanocomposite has an oriented chloride diffraction pattern with a systematic series of shoulders due to the peptide and a lower angle reflection due to the peptide layering
  • Rare earth ion oligopeptide complexed nanocomposite has a peptide-like lattice with significant enhancement of the reflections associated with planes at low angles to the peptide complex layers. Because of the highly anisotropic unit cell, planes associated with layer packing and planes associated with intermolecular packing are clustered in different regions of the diffraction trace.
  • Figure 5 depicts TEM images of poorly ordered materials
  • (a) pure oligopeptide image reveals little contrast other than the fluctuations associated with amorphous material
  • (b) chloride containing peptide (short peptide) is also largely amorphous, but small weakly ordered regions occur with a pattern matching the layer spacing observed in X-ray studies (arrows).
  • Figure 6 depicts TEM images of short oligopeptide complexed with a high proportion of Gd ion.
  • (a) Low magnification image indicates a highly grainy structure and grain boundary-like defects in the interiors of grains, suggesting a defect phase
  • (b) Higher maginification image of one of the grains showing strong layer contrast corresponding to the spacing measured in X-ray diffraction.
  • Figure 7 depicts (a): Magnetic susceptibility of a Gd bonded collagen-like oligopeptide.
  • the inset shows ⁇ (T) "1 vs. T emphasizing the Curie law behavior
  • (b): Isothermal magnetization at T 5.0 K.
  • the Brillouin function, dashed line, has no free parameters.
  • Figure 8 depicts (a): Magnetic susceptibility of a Dy bonded collagen-like oligopeptide.
  • (b): Isothermal magnetization at T 5.0 K. The saturation magnetization is much lower than the Brillouin function is derived using the data of Fig.
  • Regions with regular 7 micron stripe patterns are interspersed among more disordered regions, (b) EDTA complexed interfacial film, FESEM, 1 kN. A more disordered version of the same striped texture is observed, although there are some regions (example is circled) where regular striped order is preserved.
  • Figure 10 depicts oligopeptide precipitates with high EDTA content.
  • Figure 11 depicts peptide flake with sequence (Glu) 5 (Gly-Ala-Gly-Ala-Gly- Ser) 4 (Glu) 5 used to nucleate ordered rows of uranyl acetate crystals. Left: polarized light image. Right: normal light image.
  • Figure 12 depicts lamellar crystals of collagen-like peptide obtained from peptide/EDTA solution.
  • Figure 13 depicts typical texture for a collagen peptide in triple helical conformation and smectic long-range ordered phase, complexed with salts. The excess salt migrates to systematic defects in the smectic liquid crystal.
  • Figure 14 depicts Left: a) Beam path through a cross section of pure peptide flake(E 5 [GSPGPP] 6 E5 dried at 3 C); Right: b) Beam path through face of flake.
  • Figure 15 depicts a) pure collagen peptide in a hexatic liquid crystalline phase typically froms characteristic spherulitic structures.
  • Figure 17 depicts detail of the smectic C* spherulitic liquid crystalline texture ' obtained from a collagen peptide Rubipy complex. The two images were taken using different relative sample rotations in the polarizing microscope. The bright blue birefringent pattern follows the contours of the peptide-like spherulitic structure as the texture (the sample) is rotated in the polarizing microscope. This result strongly suggests peptide Rubipy complexation within the liquid crystal.
  • smectic is art-recognized and refers to the mesomorphic phase of a liquid crystal in which molecules are closely aligned in a distinct series of layers, with the axes of the molecules lying perpendicular to the plane of the layers.
  • gel is art-recognized and refers to a colloid in which the disperse phase has combined with the dispersion medium to produce a semisolid material.
  • hydrogel is art-recognized and refers to a colloid in which the particles are in the external or dispersion phase and water is in the internal or dispersed phase.
  • amino acid is art-recognized and refers to all compounds, whether natural or synthetic, which include both an amino functionality and an acid functionality, including amino acid analogs and derivatives.
  • amino acid residue and “peptide residue” are art-recognized and refer to an amino acid or peptide molecule without the -OH of its carboxyl group.
  • amino acid residue further includes analogs, derivatives and congeners of any specific amino acid referred to herein, as well as C-terminal or N- terminal protected amino acid derivatives (e.g. modified with an N-terminal or C-terminal protecting group).
  • the names of the natural amino acids are abbreviated herein in accordance with the recommendations of IUPAC-IUB.
  • polypeptide(s) is art recognized and refers to any peptide or protein comprising two or more a ino acids joined to each other by peptide bonds or modified peptide bonds. "Polypeptide(s)” refers to both short chains, commonly referred to as peptides, ohgopeptides and oligomers and to longer chains generally referred to as proteins. Polypeptides may comprise amino acids other than the 20 gene encoded amino acids.
  • Polypeptide(s) include those modified either by natural processes, such as processing and other post-translational modifications, but also by chemical modification techniques. Such modifications are well described in basic texts and in more detailed monographs, as well as in a voluminous research literature, and they are well known to those of skill in the art. It will be appreciated that the same type of modification may be present in the same or varying degree at several sites in a given polypeptide. Also, a given polypeptide may comprise many types of modifications. Modifications can occur anywhere in a polypeptide, including the peptide backbone, the amino acid side-chains, and the amino or carboxyl termini.
  • Modifications include, for example, acetylation, acylation, ADP-ribosylation, amidation, covalent attachment of flavin, covalent attachment of a heme moiety, covalent attachment of a nucleotide or nucleotide derivative, covalent attachment of a lipid or lipid derivative, covalent attachment of phosphotidylinositol, cross-linking, cyclization, disulfide bond formation, demethylation, formation of covalent cross-links, formation of cysteine, formation of pyroglutamate, formylation, gamma-carboxylation, GPI anchor formation, hydroxylation, iodination, methylation, myristoylation, oxidation, proteolytic processing, phosphorylation, prenylation, racemization, glycosylation, lipid attachment, sulfation, gamma-carboxylation of glutamic acid residues, hydroxylation and ADP-ribosylation, selenoylation
  • Polypeptides may be branched or cyclic, with or without branching. Cyclic, branched and branched circular polypeptides may result from post-translational natural processes and may be made by entirely synthetic methods, as well.
  • the term "transition metal” is an art-recognized term that includes the following elements: Sc, Ti, V, Cr, Mn, Fe, Co, Ni, Cu, Zn, Y, Zr, Nb, Mo, Tc, Ru, Rh, Pd, Ag, Cd, La, Hf, Ta, W, Re, Os, hr, Pt, Au, and Hg. A transition metal is often classified by the row in the Periodic Table in which it appears.
  • first row transition metal includes the following elements: Sc, Ti, V, Cr, Mn, Fe, Co, Ni, Cu, and Zn.
  • second row transition metal includes the following elements: Y, Zr, Nb, Mo, Ru, Rh, Pd, Ag, and Cd.
  • third row transition metal includes the following elements: La, Hf, Ta, W, Re, Os, Ir, Pt, Au, and Hg.
  • metaloid is an art-recognized term that includes the following elements: B, Si, Ge, As, Sb, Te, and Po.
  • aliphatic is an art-recognized term and includes linear, branched, and cyclic alkanes, alkenes, or alkynes. In certain embodiments, aliphatic groups in the present invention are linear or branched and have from 1 to about 20 carbon atoms.
  • alkyl is art-recognized, and includes saturated aliphatic groups, including straight-chain alkyl groups, branched-chain alkyl groups, cycloalkyl (alicyclic) groups, alkyl substituted cycloalkyl groups, and cycloalkyl substituted alkyl groups.
  • a straight chain or branched chain alkyl has about 30 or fewer carbon atoms in its backbone (e.g., C ⁇ -C 30 for straight chain, C 3 -C 30 for branched chain), and alternatively, about 20 or fewer.
  • cycloalkyls have from about 3 to about 10 carbon atoms in their ring structure, and alternatively about 5, 6 or 7 carbons in the ring structure.
  • "lower alkyl” refers to an alkyl group, as defined above, but having from one to ten carbons, alternatively from one to about six carbon atoms in its backbone structure.
  • lower alkenyl and lower alkynyl have similar chain lengths.
  • aralkyl is art-recognized, and includes alkyl groups substituted with an aryl group (e.g., an aromatic or heteroaromatic group).
  • alkenyl and alkynyl are art-recognized, and include unsaturated aliphatic groups analogous in length and possible substitution to the alkyls described above, but that contain at least one double or triple bond respectively.
  • heteroatom is art-recognized, and includes an atom of any element other than carbon or hydrogen.
  • heteroatoms include boron, nitrogen, oxygen, phosphorus, sulfur and selenium, and alternatively oxygen, nitrogen or sulfur.
  • aryl is art-recognized, and includes 5-, 6- and 7-membered single-ring aromatic groups that may include from zero to four heteroatoms, for example, benzene, naphthalene, anthracene, pyrene, pyrrole, furan, thiophene, imidazole, oxazole, thiazole, triazole, pyrazole, pyridine, pyrazine, pyridazine and pyrimidine, and the like.
  • aryl groups having heteroatoms in the ring structure may also be referred to as "aryl heterocycles" or “heteroaromatics.”
  • the aromatic ring may be substituted at one or more ring positions with such substituents as described above, for example, halogen, azide, alkyl, aralkyl, alkenyl, alkynyl, cycloalkyl, hydroxyl, alkoxyl, amino, nitro, sulfhydryl, imino, amido, phosphonate, phosphinate, carbonyl, carboxyl, silyl, ether, alkylthio, sulfonyl, sulfonamido, ketone, aldehyde, ester, heterocyclyl, aromatic or heteroaromatic moieties, - CF 3 , -CN, or the like.
  • aryl also includes polycyclic ring systems having two or more cyclic rings in which two or more carbons are common to two adjoining rings (the rings are "fused rings") wherein at least one of the rings is aromatic, e.g., the other cyclic rings may be cycloalkyls, cycloalkenyls, cycloalkynyls, aryls and/or heterocyclyls.
  • ortho, meta and para are art-recognized and apply to 1,2-, 1,3- and 1,4- disubstituted benzenes, respectively.
  • the names 1,2-dimethylbenzene and ortho-dimethylbenzene are synonymous.
  • heterocyclyl and “heterocyclic group” are art-recognized, and include 3- to about 10-membered ring structures, such as 3- to about 7-membered rings, whose ring structures include one to four heteroatoms. Heterocycles may also be polycycles.
  • Heterocyclyl groups include, for example, thiophene, thianthrene, furan, pyran, isobenzofuran, chromene, xanthene, phenoxathiin, pyrrole, imidazole, pyrazole, isothiazole, isoxazole, pyridine, pyrazine, pyrimidine, pyridazine, indolizine, isoindole, indole, indazole, purine, quinolizine, isoquinoline, quinol ne, phthalazine, naphthyridine, quinoxaline, quinazoline, cinnoline, pteridine, carbazole, carboline, phenanthridine, acridine, pyrimidine, phenanthroline, phenazine, phenarsazine, phenothiazine, furazan, phenoxazine, pyrrolidine
  • the heterocyclic ring may be substituted at one or more positions with such substituents as described above, as for example, halogen, alkyl, aralkyl, alkenyl, alkynyl, cycloalkyl, hydroxyl, amino, nitro, sulfhydryl, imino, amido, phosphonate, phosphinate, carbonyl, carboxyl, silyl, ether, alkylthio, sulfonyl, ketone, aldehyde, ester, a heterocyclyl, an aromatic or heteroaromatic moiety, -CF 3 , -CN, or the like.
  • substituents as described above, as for example, halogen, alkyl, aralkyl, alkenyl, alkynyl, cycloalkyl, hydroxyl, amino, nitro, sulfhydryl, imino, amido, phosphonate, phosphinate, carbonyl, carboxy
  • polycyclyl and “polycyclic group” are art-recognized, and include structures with two or more rings (e.g., cycloalkyls, cycloalkenyls, cycloalkynyls, aryls and/or heterocyclyls) in which two or more carbons are common to two adjoining rings, e.g., the rings are "fused rings". Rings that are joined through non-adjacent atoms, e.g., three or more atoms are common to both rings, are termed "bridged" rings.
  • Each of the rings of the polycycle may be substituted with such substituents as described above, as for example, halogen, alkyl, aralkyl, alkenyl, alkynyl, cycloalkyl, hydroxyl, amino, nitro, sulfhydryl, imino, amido, phosphonate, phosphinate, carbonyl, carboxyl, silyl, ether, alkylthio, sulfonyl, ketone, aldehyde, ester, a heterocyclyl, an aromatic or heteroaromatic moiety, -CF 3 , -CN, or the like.
  • substituents as described above, as for example, halogen, alkyl, aralkyl, alkenyl, alkynyl, cycloalkyl, hydroxyl, amino, nitro, sulfhydryl, imino, amido, phosphonate, phosphinate, carbonyl, carboxyl, si
  • Carbocycle is art recognized and includes an aromatic or non-aromatic ring in which each atom of the ring is carbon.
  • the flowing art-recognized terms have the following meanings: “nitro” means -NO ; the term “halogen” designates -F, -Cl, -Br or -I; the term “sulfhydryl” means -SH; the term “hydroxyl” means -OH; and the term “sulfonyl” means -SO 2 " .
  • amine and “amino” are art-recognized and include both unsubstituted and substituted amines, e.g., a moiety that may be represented by the general formulas:
  • R50, R51 and R52 each independently represent a hydrogen, an alkyl, an alkenyl, - (CH ) m -R61, or R50 and R51, taken together with the N atom to which they are attached complete a heterocycle having from 4 to 8 atoms in the ring structure;
  • R61 represents an aryl, a cycloalkyl, a cycloalkenyl, a heterocycle or a polycycle; and
  • m is zero or an integer in the range of 1 to 8.
  • only one of R50 or R51 may be a carbonyl, e.g., R50, R51 and the nitrogen together do not form an imide.
  • R50 and R51 each independently represent a hydrogen, an alkyl, an alkenyl, or -(CH 2 ) m -R61.
  • alkylamine includes an amine group, as defined above, having a substituted or unsubstituted alkyl attached thereto, i.e., at least one of R50 and R51 is an alkyl group.
  • acylamino is art-recognized and includes a moiety that may be represented by the general formula:
  • R50 is as defined above, and R54 represents a hydrogen, an alkyl, an alkenyl or - (CH 2 ) m -R61, where m and R61 are as defined above.
  • R54 represents a hydrogen, an alkyl, an alkenyl or - (CH 2 ) m -R61, where m and R61 are as defined above.
  • the term "amido" is art recognized as an amino-substituted carbonyl and includes a moiety that may be represented by the general formula:
  • alkylthio is art recognized and includes an alkyl group, as defined above, having a sulfur radical attached thereto.
  • the "alkylthio" moiety is represented by one of -S-alkyl, -S-alkenyl, -S-alkynyl, and -S-(CH 2 ) m -R61, wherein m and R61 are defined above.
  • Representative alkylthio groups include methylthio, ethyl thio, and the like.
  • carbonyl is art recognized and includes such moieties as may be represented by the general formulas:
  • X50 is a bond or represents an oxygen or a sulfur
  • R55 represents a hydrogen, an alkyl, an alkenyl, -(CH 2 ) m -R6 lor a pharmaceutically acceptable salt
  • R56 represents a hydrogen, an alkyl, an alkenyl or -(CH 2 ) m -R61, where m and R61 are defined above.
  • Wliere X50 is an oxygen and R55 or R56 is not hydrogen, the formula represents an "ester”.
  • X50 is an oxygen
  • R55 is as defined above, the moiety is referred to herein as a carboxyl group, and particularly when R55 is a hydrogen, the formula represents a "carboxylic acid".
  • X50 is an oxygen, and R56 is hydrogen
  • the formula represents a "formate".
  • the oxygen atom of the above formula is replaced by sulfur
  • the formula represents a "thiocarbonyl” group.
  • X50 is a sulfur and R55 or R56 is not hydrogen
  • the formula represents a "tliioester.”
  • X50 is a sulfur and R55 is hydrogen
  • the formula represents a "thiocarboxylic acid.”
  • X50 is a sulfur and R56 is hydrogen
  • the formula represents a "thioformate.”
  • the above formula represents a "ketone" group.
  • Wliere X50 is a bond, and R55 is hydrogen, the above formula represents an "aldehyde” group.
  • alkoxyl or “alkoxy” are art recognized and include an alkyl group, as defined above, having an oxygen radical attached thereto. Representative alkoxyl groups include methoxy, ethoxy, propyloxy, tert-butoxy and the like.
  • An “ether” is two hydrocarbons covalently linked by an oxygen.
  • an alkyl that renders that alkyl an ether is or resembles an alkoxyl, such as may be represented by one of -O-alkyl, -O-alkenyl, -O-alkynyl, -O-(CH 2 ) m -R61, where m and R61 are described above.
  • alkoxyl such as may be represented by one of -O-alkyl, -O-alkenyl, -O-alkynyl, -O-(CH 2 ) m -R61, where m and R61 are described above.
  • sulfonate is art recognized and includes a moiety that may be represented by the general formula: O
  • R57 is an electron pair, hydrogen, alkyl, cycloalkyl, or aryl.
  • sulfate is art recognized and includes a moiety that may be represented by the general formula: O -o- -OR57
  • R50 O in which R50 and R56 are as defined above.
  • the term "sulfamoyl” is art-recognized and includes a moiety that may be represented by the general formula:
  • R58 is one of the following: hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl or heteroaryl.
  • sulfoxido is art recognized and includes a moiety that may be represented by the general fonnula:
  • R60 represents a lower alkyl or an aryl.
  • Analogous substitutions may be made to alkenyl and alkynyl groups to produce, for example, aminoalkenyls, aminoalkynyls, amidoalkenyls, amidoalkynyls, iminoalkenyls, iminoalkynyls, thioalkenyls, thioalkynyls, carbonyl-substituted alkenyls or alkynyls.
  • the definition of each expression e.g.
  • alkyl, m, n, etc. when it occurs more than once in any structure, is intended to be independent of its definition elsewhere in the same structure unless otherwise indicated expressly or by the context.
  • the chemical elements are identified in accordance with the Periodic Table of the Elements, CAS version, Handbook of Chemistry and Physics, 67th Ed., 1986-87, inside cover. Overview
  • Rare earth ions are relatively non-toxic and have been used as magnetic "dyes" to enhance contrast in magnetic resonance medical imaging.
  • Use of rare earth magnetic tags to control magnetically the organization of a biomaterial is an important application for nanolayered composites.
  • protein and peptide chemistry provides avenues to change the shape and physical chemistry of a constituent molecule during processing.
  • oligopeptide materials of the instant invention are biopolymers, they do not behave like traditional folded proteins. Most proteins fold into compact globular structures stabilized by intramolecular interactions. In contrast, these oligopeptide materials favor strong intermolecular interactions, which lead to partial ordering in smectic liquid crystalline phases and result in a molecular solid with reasonable thermal stability, toughness, and strength.
  • the ohgopeptides of the present invention have been designed as model molecules that allow one to take advantage of their liquid crystalline behavior to promote self- assembly of materials patterning at the nano-, micro- and even meso-scales.
  • a feature of this approach includes designing molecular materials that 'segregate to form nanoscale long- range ordered patterns as a thermodynamically favorable state, often through built-in molecular chemical complexity resulting in thermodynamic "frustration".
  • biopolymer liquid crystals as templating molecules eliminates some of these constraints., while providing a wider range of potential materials-processing avenues.
  • the "chain" of magnetic ions is clearly defined and predictable because it is defined using a covalently bonded macromolecule, rather than less predictable and controllable associations between complex small molecules.
  • Biopolymers are inherently chiral, and the combination of chiral centers and a chiral secondary structure ensures that all of the magnetic ions are in a chiral environment.
  • the liquid crystalline nature of the molecules ensures the alignment and order necessary to produce a strong local field and to align preferred magnetic axes.
  • the chemical pattern and monodispersity of biopolymer systems will stabilize smectic layered structures.
  • peptide organic materials in combination with rare earth ions and complexed rare earth chlorides are presently disclosed.
  • the largest of these peptides is designed to mimic the behavior of collagen, and is expected to produce a material with layers of about 10 nm thickness.
  • Another peptide is analogous to the fibrous protein of silk, and is shorter, with an expected linear dimension of about 4.5 nm.
  • Yet another peptide was designed with a silk-like sequence and an expected linear dimension of about 4.7 nm. Any of these peptides may be terminated on both ends by a sequence of acidic amino acids, providing binding sites for added metal ions, such as gadolinium and dysprosium.
  • the collagen-like oligopeptide may have five acids on each end of each chain, resulting in fifteen negative charges for each fully ioninized acidic end of a triple helix (collagen adopts a state where three chains twine together into a rigid triple helix). These two ions were selected because of their ease of preparation and because their magnetic properties differ fundamentally.
  • the ohgopeptides tend to self-assemble smectically, so the rare earth ions are arrayed in 2-D sheets of thickness 1-2 nm, separated by the length of the peptide molecules.
  • synthesis protocols similar to that outlined below a very wide variety of magnetic and non-magnetic rare earths and/or transition metals may be incorporated into these quasi 2-D layers.
  • the amino acid sequence of the oligopeptide and the length of the liquid crystal forming subsequence or "block” determine the separation between the rare earth layers in these materials, as shown schematically in Fig. la.
  • the linear ohgopeptides used in these studies have been observed to form smectic liquid crystalline phases, which are easily identified by comparing their polarizing optical "fingerprints” with other smectic structures and fingerprints pervading the literature (our group, unpublished data).
  • the ohgopeptides contain chemically distinct regions in their molecular sequences, as shown in Fig. la, and the major volume fraction of each oligopeptide can form a secondary or supersecondary structure, which acts as a rigid rod.
  • oligopeptide template can be designed to form a rigid anisotropic structure at high concentrations, allowing the molecule to be dissolved as a soluble and easily processed flexible molecule which forms rigid structures as solvent (pure water) is dried off.
  • the resulting materials are often glassy, but retain long-range ordered features typical of a liquid crystal, such as oriented microstructures.
  • the collagen-like ohgopeptides of the present invention have this characteristic.
  • each oligopeptide molecule In dilute solution at room temperature, each oligopeptide molecule is flexible. At low temperatures and high concentrations these molecules aggregate into rigid triple helical ropes and exhibit a variety of liquid crystalline phases.
  • These highly anisotropic molecular shapes limit the packing possibilities between nearest neighbor triple helical ropes, essentially assuring a material comprised of aligned ropes or "rods".
  • Smectic liquid crystalline phase behavior provides registry between chemical patterns written into the rods, resulting in layered peptide and rare earth enriched microstructures.
  • the result is a predictable pattern of peptide and rare earth enriched layers throughout the material.
  • glassy materials are observed with no evidence of layering in experiments with anisotropic oligopeptide template molecules having less anisotropic shapes.
  • the peptide matrix is deformable, allowing localized changes in the structure of the peptide layers, due to magnetic ordering and interactions, without introducing a high density of dislocations and reducing potential material failure due to fatigue.
  • Elastic nanostructured materials can be designed. In the liquid crystalline liquid or viscoelastic "gel" state, the rigid rod molecules in the peptide phase can sustain significant reorientations involving negligible latent heat.
  • non-peptide oligomers may be possible, resulting in a variety of materials properties.
  • Peptide chemistry is well-developed, yielding sequence control for peptide polymers with a range of molecular weights, and a well elucidated synthetic scale-up methodology.
  • these molecules will allow the development of general methods for producing nanopatterned polymer matrix composites through self- assembly and other facile assembly techniques.
  • the self-assembly of the long, linear ohgopeptides in smectic arrays causes the rare earths to form 1-2 nm thick layers.
  • the peptide amino acid sequence controls the distance between layers. While the data show nearly perfect rare earth paramagnetic behavior over a very wide range of temperature, some evidence is seen at the lowest temperature for precursor ordering among the Dy ions, but only for the shorter (4 nm) layer separation, perhaps due to greater interlayer correlations. The influence of crystalline electric fields from surrounding ions is evident in the difference in the behavior of Dy-layered materials from Gd-layered materials in both the collagen-like and silk-like materials.
  • Short, stable ⁇ -helical sequences, and ⁇ -sheet crystallizable sequences are used explicitly for this purpose.
  • these known motifs are combined with distinct endcapping sequences, which are selected to provide a pattern of metal binding sites.
  • the helical or crystallizable sequence is selected to provide a chemical and/or side chain size disparity with the patterned metal binding sequences, resulting in layering and a sharp separation between the different domains due to thermodynamically unfavorable mixing of chemically and physically disparate monomers/segments in the same material domain.
  • This physical process is essentially the same as the one driving microphase separation in strongly segregated block copolymers.
  • Such materials can be engineered to provide a direct electronic readout of changes in the peptide domains, where the peptide domains may be designed to sense, or to perform analog chemical and biological computation functions.
  • sequence motifs must be selected which allow portions of the metal binding patterns to overlap with the helix forming patterns.
  • E A A A K there is an acid base bridge formed by acidic glutamic acid (E) and basic lysine (K), separated by three hydrophobic amino acids (alanine - A).
  • E acidic glutamic acid
  • K basic lysine
  • alanine - A hydrophobic amino acids
  • the entire 5-monomer sequence is slightly less than 1 nm long.
  • hydrophobic cysteine (C) can be substituted for alanine.
  • the resulting sequence E A A C H can still form layered structures of ⁇ -helices, but the farthest distance between metal ions/atoms has been reduced to roughly 6 Angstroms.
  • the ⁇ -helical conformation is known to accommodate side chains significantly larger than a metal atom or even a small to medium sized side chain with an attached bound metal atom. The metals will thus be localized (by the metal binding side chains) into areas of the helix where they are unlikely to severely disrupt the structure and the resulting layering within the material.
  • ⁇ -helical sequences include: EEEAAAKEEE, EECCAKEECE, EEEGAGAGSEEE, NNECACKCCNE, EAAKEAAAK, CCEAAAKDAAHC, and HCAAEAAAKCH.
  • Chiral oligomeric molecules - rigid rod copolymers (in this case peptides) - have been designed to incorporate a self-fabricating helical rigid rod sequence which incorporates a pattern of binding functionalities at either the N-terminus, the C-terminus or at both termini.
  • the rigid rod behavior of the oligomer block combined with chemical (enthalpic) and structural (rigidity - entropic) disparities between the central portion and the end areas (patterned with binding sequences) favor the formation of a nanolayered structure, where each total layer thickness is determined by the length (molecular weight) of the oligomers.
  • Sublayer regions are determined by the length of the central rigid-rod forming portion of the sequence and the size of the amino acids comprising the metal binding domains.
  • the second component in this case consisting of patterned metal binding domains, is forced into a strained configuration, leading to very active absorption and binding of metal ions as well as other unique properties, a cocrystallized composite, both the crystallizable portion of the peptide sequence and the metal functionalized binding domains crystallize, resulting in a three dimensional ordered pattern of monomers which is "programmed in” at the sequence design level.
  • These programmed patterns of monomers localized in specific material sublayers can in turn be used to localize added metallic, inorganic, or organometallic molecules and ions to create precisely specified patterns.
  • Co- crystallization of rare earth ions with acidic amino acid binding domains is demonstrated, and a high degree of sublayer localization and in-layer ordering is observed.
  • Co-crystallization of rare earth ions with oligopeptide patterns that also bind transition metals is also envisioned as a way to create novel intermetallic complexes.
  • the simplest binding sites are amino acids with known element specific binding affinities such as histidine for nickel and cysteine for gold. Short combinations of amino acids maybe used to bind a range of metals, semiconductors, and organometallic and inorganic phases.
  • the oligomeric molecules are designed so that (in terms of monomers making up the oligopeptide) the mole fraction of monomers in the self-fabricating portion is significantly greater than the mole fraction of monomers in the functional patterned ends (by a factor of at least 1.5).
  • the result of a molecular design which consists of a large self- fabricating unit and smaller solubilizing/functional ends, is that the thermodynamically favorable state for the entire molecule will be similar to the thermodynamically favorable state for the self-fabricating or crystallizable peptide region. There may be a structural compromise due to the presence of the binding pattern, especially where the rigid-rod and pattern and binding pattern can share a motif and overlap.
  • the present invention enables the design of frustrated smectically ordered solids and layered "composite" crystalline solids, where the density and interaction behavior in the interlayer region is strongly perturbed with respect to bulk material or non-frustrated surfaces with the same composition.
  • smectic forming (and crystallizable interchain stabilized) "self- fabricating" sequences, oligomeric molecular weight and associated liquid to solid transitions, and a nanoscopic designed frustrated interlayer region allows one to construct molecularly designed materials with nanoscale fluid channels.
  • These channels are essentially the chain end (patterned metal binding) regions in the multilayered smectic-generated or layered crystalline structures. Tlirough engineered mismatching of the properties of monomers used to specify the monomers in the ends which do not specifically bind and pattern metals (the spacer monomers) versus the rigid rod or highly interchain stabilized crystallizable regions, various properties may be designed into the channels.
  • the regions in question contain chain ends, they are somewhat less constrained than the other portions of the molecule and self-fabricated material.
  • the chain ends protruding into the interlayer region create a brush at the molecular scale.
  • Molecules absorbed into the material will migrate preferentially into the interlayer regions because: (1) The interlayer region has a lower density and also swells more easily; (2) The interlayer region is in a locally thermodynamically unstable state; (3) The rigid rod or interchain stabilized crystallizable molecular structures (and thus portions of the sequence) interact along their entire length; the layer regions comprised of these portions of the molecules are less tolerant of additives; and (4) Chemical interactions can be designed into solubilizing and metal patterning end sequences, and thus into the interlayer region, at the molecular sequence level to promote diffusion and binding of a second (metallic) component.
  • Designed interactions may include acidic amino acids in the metal patterning regions to attract and localize basic solutes, low amino acid volumes for the spacers in the metal patterning regions or domains to attract solute molecules that balance the interlayer volume and density, or matched metal patterning sequence-solute hydrophobic/hydrophilic interactions. It is important to note that the "solute localizing" properties designed for the metal patterning regions/domains need not be entirely enthalpic (chemical interactions) in nature, but can include entropy-based design ideas as well (volume, molecule shape, flexibility). Thin films can be prepared using dilute solutions of the peptide and inorganic (or organometallic) component.
  • the chemistry of the solid surface used to cast the thin film will control the orientation of the nanoscale layers in the material.
  • the key feature of this chemical control is the anchoring interaction between the peptide end groups, the amino acids on the end of the rod-like portion of the peptide, and the solid surface. These interactions can be designed based on models, literature data on surface anchoring of various chemical groups, and interpolation/extrapolation of our own experimental results. Chiral features can be either incorporated or damped out in the material by the selection of amino acid side chains in the rigid-rod-like portion. All of the peptide rigid rods are based on simple repetitive patterns or "motifs" of amino acids. However, different amino acids with similar chemistry can be substituted at many points along the motif, allowing us to design variations in side chain size.
  • Rare-earth metal Peptide Matrix Nanocomposites may comprise one or more peptides with rigid rod center blocks combined with acidic endbolocks.
  • the molecules can be made biosynthetically (a cheap scalable process) or chemically.
  • the structured designed peptides are mixed with solutions of basic rare earth ions, typically prepared by dissolving oxides in weak hydrochloric acid.
  • the type of ordered composite obtained is controlled by controlling the drying time and temperature of the mixture and can be altered by adding precipitants, such as ethers and alcohols.
  • the length of the rigid rod sequence determines the thickness of the peptide layers in the material.
  • the lengths of the endblock sequences determine the thickness of the metallized layers.
  • the rigid rod portions can be ⁇ -helical sequences of about 5-60 amino acids in length. The ⁇ -helical sequences are especially interesting because short sequences will form stable layered structures, allowing us to access nanoscale length scales.
  • the thinnest ordered peptide layer achieved by our group in a metal layered composite was about 0.8 nm with an ⁇ -helical sequence.
  • the ⁇ -helix also has a very strong molecular electric dipole, which is essentially parallel to the long axis of the helix (rigid rod). This dipole can be used to align the helices and to create complex textures such as the square grid patterns formed by liquid crystals in electric fields.
  • the ⁇ -helical rigid rods are only weakly chiral (don't tend to twist).
  • the acidic endblocks ranged from 1 amino acid in length to lengths equal to the ⁇ - helical sequence. Layered structures ranging down to subnanometer rare earth layers and peptide layers have been fabricated using the simple technique described above.
  • the rigid-rod portions of the peptide can be a triple helix forming sequence; i.e., they may be collagen-like.
  • Peptide composites are prepared as described above, but at temperatures below the triple helix melting point.
  • Triple helix melting points for collagen model sequences have been well documented in the literature and can be calculated from empirically derived known formulae for common three amino acid and six amino acid motifs. Triple helix forming sequences form stable structures in solution when the sequence is at least 6 amino acids long. Sequences of greater than about 20 amino acids are stable triple helices (in solution) at ambient and near ambient temperatures. The triple helix has a weaker dipole than the ⁇ -helix, but can also be oriented in a field (electric, magnetic). It is more rigid and less smooth than the ⁇ -helix and can thus be used to make stiffer materials and patterns that require a higher tendency to twist.
  • the triple helix crystallizes a little more readily than the ⁇ -helix when metal ions are incorporated, and has a reasonable thermal stability in the solid state. In the solid state the triple helix is retained to greater than about 150 °C and the layered nanostructure is retained to higher temperatures (greater than about 200 °C). Thus it may be possible to calcine the peptide phase to create new classes of strong dry solid materials.
  • the rigid rod may be based on a sequence or sequence motif derived from native silks. Typically these are sequences containing about 33 to about 60% glycine, and a very regular alternating pattern of a few amino acid types.
  • the rigid rods formed by these sequences are folded structures, either twisted hairpins or twisted fan-like structures resembling the ⁇ -domains in globular proteins. These rigid rod domains have the general shape of twisted ribbons and thus have a high tendency to twist. In this case, the peptide phase tends to crystallize, forming a variety of crystalline polymorphs distinguished by changes in the conformation and packing of the peptide rigid rods. Sequences with rod domain lengths of greater than about 12 amino acids have the capacity to fold into rigid structures. If charged endgroups are more than 40% of the peptide amino composition, folding into a rigid structure is inhibited. Nery short silk-like sequences will crystallize as straight stems without forming rigid rods.
  • the peptide phase is stabilized by intermolecular hydrogen bonds, is highly thermally (greater than about 200 °C) and mechanically stable, and completely dominates the thermodynamics of composite self- assembly process.
  • Chemical and physical manipulation can be used to manipulate the structure of the crystalline peptide phase to control the packing of the metallic, inorganic, or organometallic phase in the interlayer region.
  • the rare-earth metals used include, but are not limited to Gd, Dy, Pr, Ce, Er, Ho and the like.
  • the composites may by baked in a vacuum oven at temperatures from about 50 to about 170 °C to remove bound water in the rare earth layers. At higher temperatures the peptide phase can be pyrolyzed to fon various carbonaceous/rare earth layered composites.
  • Rare Earth-Transition Metal Peptide Matrix Nanocomposites Composites may be prepared using the methods described above, where the peptide design includes transition metal binding sites.
  • These sites can be localized near the ends of the peptide, within the end blocks, near the ends of the rigid rod domain or can be patterned into the rigid rod domain to create a wide variety of intermetallic rare earth and transition metal patterns in a peptide matrix.
  • the transition metal can be added to the peptide through vapor deposition onto a thin peptide film, followed by surface diffusion, through chemical complexation prior to adding the rare earth or other second inorganic (or organometallic) component, deposited in a multilayer electrostatic deposition process, or the metal may be deposited onto a thin textured nanopatterned metal-peptide composite film, where the excess is rinsed off after several hours (to allow surface diffusion and binding).
  • Some peptide sequences useful for this application include the following: NGCGN(GPAGPP) 2 NGCGN, NGCGN(GAGAGA)NGCGN, C(N) 3 (GGAGNA) 6 (N) 3 C,
  • LV 5 GPCGHP GCPGPH (helical sequence)(LV) 5 .
  • Relatively heavy (electronically dense) inorganic additives are interesting because it is expected that these will impart unique optical and electronic properties to the composite materials due to strong periodic variations in electron density (and hence refractive index, electrical properties, thermal properties, etc.) in the fabricated composite.
  • the metals will be confined to the mterlamellar spacings, rather than being incorporated into the smectic layers themselves.
  • Preliminary data suggest that additional charged components can enhance crystallization of ohgopeptides, forming cocrystals, templated inorganic-organic crystals, and other types of near molecular composites.
  • the observed phenomenon is based on electrostatics; the peptides chosen will have charged end groups, favoring interaction with the charged species chosen for investigation.
  • the presence of the charged inorganic species should promote a strong bonding, coulombic or ionic in nature, between the smectic layers and layers of crystallizing peptide, enhancing the tendency to self-assemble into arrays which have three dimensional order.
  • Sample inorganic species include both cationic and anionic species, substances that have strong visible absorptions and substances that are largely transparent in the visible spectrum, substances that have strong chirality and achiral substances, and substances that are readily oxidized and reduced and undergo rapid electron exchange. All can be relatively electron dense compared to the proteinaceous lamellar layers.
  • the lightest materials will have at least one second-row transition metal, others will have up to a dozen third-row transition metals.
  • suitable inorganic materials include the following: 1) Anionic polyoxometallates, principally the isopoly- and heteropoly- molybdates and tungstates; 2) Polynuclear cationic species, such as the cluster cations Ta 6 Cl ⁇ 2+ and W 6 C1 8 4+ , or their bromide analogs; and 3) Chiral complexes, which can be added in two different stereoisomeric forms, giving rise to diastereomeric combinations with the intrinsically chiral peptides under investigation. 1) Anionic polyoxometallates, principally the isopoly- and heteropoly- molybdates and tungstates. These materials are well known and hydrolytically stable under conditions of near-neutral pH.
  • the ions of greatest interest have 12 molybdenum or tungsten atoms per unit, and thus will create a layer with extremely high electron density, and lead to a strong modulation of both X-ray and electron scattering intensities, facilitating the TEM and X-ray investigations of their structure, and a strong nano-meter scale modulation of the refractive index of the composite materials.
  • Polynuclear cationic species such as the cluster cations Ta 6 Cl ⁇ 2 2+ and W 6 C1 8 + , or their bromide analogs. These species each have six additional coordination sites for binding additional ligands, in addition to having the electrostatic interactions due to their charge.
  • Initial choices include tris-bipyridylruthenium(II) and/or related species and the classic all- inorganic tris-(tetramminedihydroxocobalt(III))cobalt(III) cation.
  • the former is chosen because it has strong fluorescence properties that should be polarized, and the latter because it has one of the largest molar rotations ever recorded, about 47,500° at the sodium D line; thus, it could contribute dramatically to the rotatory properties of the composite materials.
  • Silicates and germanium compounds are known to be nucleated and bound specifically by peptide sequences discovered through Phage display technology (Air Force). They also allow further functionalization with additional inorganics. Patterned combinations of magnetic rare-earth metals (the majority of the
  • Lanthanides and magnetic transition metals may be used to create soft magnetic domain structures in thinly to semi-thin layered materials (less than 1 nm - roughly 4 nm insulating layers). These materials will have applications as writable memory components.
  • the degree of coupling and hence magnetic "softness" and stability of the magnetic domains can be tuned by, e.g., one or more of the following: (a) combining magnetic rare earth ions with nonmagnetic transition metals; (b) lowering the concentration of metal in the layers; (c) making thinner or thicker more two-dimensional metallic layers; (d) increasing the distance between metal atoms and ions; (e) treating the composite (developing it like a metal halide film plate) to create metal clusters; (f) varying the relative concentrations of different metal ions; (g) selecting different oxidation states of the transition metals; (h) combining magnetic transition metals with non-magnetic rare earths; (i) changing the spacer amino acids in the metal patterning sequence to increase
  • Pure oligopeptide material has an unoriented polycrystalline texture with strong reflections at 2-12 nm and a moderate to weak, somewhat diffuse diffraction ring at approximately 3.7 nm. Diffraction patterns from these materials were a close match to the silk III structure, a variation on the polyglycine II and poly(Alanyl glycine) II extended threefold helices. Observed -spacings and relative intensities matched the silk III hydrate structure, a poly(alanly glycine) II helix observed in interfacial films of B. Mori silk protein, the protein sequence used to design the oligopeptide.
  • Ohgopeptides complexed with rare earth ions by dissolving the rare earth oxide directly in aqueous solutions of acidic peptide are expected to contain only peptide and rare earth ion. hi materials formed from these complexes, bound hydration water may also be present. None of the samples prepared through direct dissolution of rare earth oxide into acidic oligopeptide solutions revealed diffraction evidence of a rare earth oxide phase.
  • ⁇ (T) ⁇ 0 + C/(T- ⁇ ), (1)
  • ⁇ 0 represents the temperature independent part of the susceptibility (core diamagnetism in this case because as an insulator we expect no Pauli paramagnetism)
  • the Curie- eiss temperature is a measure of the ferro- or antiferromagnetic interactions among the magnetic constituents.
  • the inset in Fig. 7a show _1 (T) vs.
  • Magnetic susceptibility measurements such as shown in Fig. 7a, when fit to Eq. 1, provide an alternate approach to calculating the number of rare earth ions in the samples, in this case to make a determination of the Gd concentration.
  • the calculated curve underpredicts the experimental data by ⁇ 5%, an agreement with M sat B 7/2 (x) which is well within experimental error. Similar data to those in Fig. 7a and 7b are shown in Figs.
  • the dark stripes had a "braided" appearance, which is the result of layers of material stacked and twisted into a complex pattern, seen clearly at higher magnification in both FESEM and TEM images.
  • unstained high resolution energy filtered cryogenic (-167 °C) TEM image it is apparent that the smoother film regions near the braids (arrow) exhibit sharp changes in contrast, which increases in steps. This indicates discrete layers of material, oriented approximately parallel to the film surface. Similar features can be observed in the FESEM images. In the smooth film sections interspersed with the braided band texture, a faint pattern of contrast can be observed with a grid or mesh-like appearance.
  • braided stripes are distinctly visible in the FESEM images as thicker raised areas, this mesh pattern is not visible, suggesting a different mode of contrast, such as changing orientation of coherently diffracting regions, may be responsible for the TEM texture, hi several of the figures, the more highly organized lyophilized flakes are shown for comparison.
  • the presence of the texture in both air-water interface films and in lyophilized flakes suggests that the appearance of the braided film structure is a robust consequence of thick smectic layer formation, and is relatively insensitive to the chemical environment.
  • each stripe consists of a region of smaller undulating bands ( Figure 10). Close examination of these bands reveals several repeats of a very fine nanoscale pattern which occurs periodically as fine edges as the bands reorient ( Figure 10). Measurement of this very fine nanoscale pattern of layers reveals a 4-5 nm layer and a ⁇ 1 nm layer alternating every other layer. These dimensions are very consistent with the dimensions predicted for the SpidN molecule in a hairpin configuration and arranged in layers.
  • Single Crystals Single crystals of all of the peptides could be obtained by either crystallizing with EDTA or tlirough agitation of lyophilized peptide powder in a poor solvent, such as 80% ethanol/20% water. In most cases the quality of the crystals obtained was poor, yielding few reflections in electron diffraction experiments. A notable exception was SpidN, which produced high quality lamellae in both crystallization procedures. Studies with SpidN crystallized in poor solvent, where EDTA impurities are not a concern, provided additional insight into the dimensions of the peptide hairpin and the layer thicknesses.
  • a diffraction tilt series of a lamella indicate that the reciprocal lattice is comprised of relrods - elongated tubes of intensity at each lattice point. Furthermore, these relrods are oriented with their long axes perpendicular to the Ewald plane in a zero tilt condition. Relrods in a diffraction pattern are the result of a stacked planar structure, and the orientation of the relrods indicates that the planes in the real space structure are parallel to the surface of the support film - the plane normals are parallel to the electron beam. A layer spacing of ⁇ 4 nm is obtained from the spacing of the nodes of high intensity along each relrod.
  • the 4 nm layer spacing is expected to correspond to planes at some (small) angle to the (0 0 1) planes and to have a smaller interplanar spacing than the 0 0 1 dimension, which represents a true layer spacing in the crystallites.
  • the ⁇ 001 ⁇ reflections are not silk-like, but instead consist of a strong small angle reflection at 4.2 nm and weaker reflections which can be indexed as orders of a 4.2 nm layer spacing.
  • the distribution of diffracted intensity is a striking combination of meridionally and equatorially centered streaks with no apparent offset reflections, again indicating only ⁇ hkO ⁇ and ⁇ 001 ⁇ reflections are present.
  • Spectroscopic Methods Sample purity after crystallization was examined tlirough FTIR spectroscopy and FTIR microscopy using a Bruker Equinox 55 Spectrometer with FTIR microscope attachment. For FTIR microscopy, 300 scans were averaged for both background and sample data collection, and a resolution of 4 cm "1 was used. Materials were characterized using polarizing optical microscopy, TEM, and SEM. A Nikon polartizing optical microscope was used in transmission mode to analyze the materials. TEM was performed on unstained samples with a LEO 922 energy filtering TEM, operated at 200 kN, using a cryogenic sample stage and on a Philips CM10 TEM operated at 100 kN using standard sample handling.
  • FibV (Glu) 5 (Ser-Gly-Ala-Gly-Nal-Gly-Arg-Gly-Asp-Gly-Ser-GlyNal-Gly-Leu-Gly-Ser- Gly-Asn-Gly) 2 (Glu) 5
  • FibCl (Glu) 5 (Gly-Ala-Gly-Ala-Gly-Ser) 4 (Glu) 5
  • FibC2 (Glu) 6 (Gly-Ala-Gly-Ala-Gly-Ser) 3 (Glu) 6 ,
  • FibAl (Glu) 5 (Gly-Ala-Gly-Ala-Gly-Tyr) 4 (Glu) 5 , and
  • FibA2 (Glu) 6 (Gly-Ala-Gly-Ala-Gly-Tyr) 3 (Glu) 6 .
  • the peptides were synthesized using standard Fmoc synthesis and purified using HPLC with trifluoroacetic acid as solvent. Mass spectrometry was used to assay the molecular weight and purity of the peptides, which were monodisperse to within measurement accuracy and within 0.01% of the calculated molecular weight. Peptides arrived as lyophilized powders. The peptides were soluble in pure water (17 M ⁇ Millipore filtered water) to concentrations in excess of 50 mg/ml. Crystallization, bulk smectic formation and interfacial film formation were all promoted by neutralizing the glutamic acid ends of the peptide.
  • a number of bases effectively neutralize the charge on the glutamic acid (Glu) ends of the peptides, facilitating self-assembly into materials.
  • Glu glutamic acid
  • ⁇ a + EDTA " bipyridyl tris RuII chloride hexahydrate
  • metallic bases a number of metallic bases.
  • a series of interfacial films from peptides dissolved in pure water and in aqueous solutions of peptide treated with Na + EDTA " were studied. Thin films from aqueous solutions of dissolved peptide were also compared with as received lyophilized flakes (where the solvent purification process may encourage thick interfacial films). Single crystals were also grown from these aqueous peptide solutions.
  • Crystals were prepared from the peptide by adding NA + EDTA " to peptide solutions to neutralize the chain ends, and then crystallizing with ethanol. Crystallization was monitored by eye TEM samples were acquired by dropping cloudy solutions (containing crystal nuclei and small crystallites) onto carbon coated TEM grids. Crystals from different stages in the crystallization process were collected and examined using FTLR microscopy (Bruker equinox 55) to determine the relative amounts of peptide (characteristic protein Amide bands) and EDTA content.
  • FTLR microscopy Bruker equinox 55
  • Example 1 Thin Films of silk-like olisopeptides complexed with EDTA: Peptides from the list above were dissolved in deionized water, without heating. Solution concentrations of 10 mg/ml to 100 mg/ml were used, depending on the solubility of individual peptides. Solutions of peptide/EDTA complex were prepared by adding sodium EDTA solution (pH greater than or equal to 8) to the peptide solution to obtain a charge balance, assuming full ionization of both peptide and EDTA. Thin solid films formed at the surface of the peptide solutions after 3-30 minutes ( Figure 9), which were collected and examined.
  • Example 2 Bulk crystals of silk-like olisopeptides complexed with EDTA: The peptide solutions could also be used to crystallize peptide crystals complexed with EDTA and peptide EDTA organic/organic layered nanocomposites. EDTA and peptide solutions were prepared as in Example 1. Alcohols (methanol, ethanol and propanol) were used to precipitate the complex from solution. Alcohol was added to the peptide EDTA solutions in an excess of at least 2:1 alcohol to peptide/EDTA solution. Peptide crystals with very low EDTA content ( ⁇ approx.
  • Uranyl acetate is an Organometallic compound known to complex to acidic regions in polymers and is often used as an acid sensitive negative stain in electron microscopy. Controlled nucleation of Uranyl acetate using a patterned peptide thin film. Silk-like hairpin peptide sequences, described in example 1, were used. During the purification process, these peptides are dissolved in trifluoroacetic acid and lyophilized. This process results in textured flakes similar to those obtained from the thin film preparation in Example 1 ( Figure 9a).
  • Silk-like peptides complexed with Rubipy (bipyridyl tris Rufll) chloride hexahydrate): "Rubipy” is not commonly used as a stain, but is also basic and should complex to free acids. Textured silk-like (hairpin - sequences from example 1) peptide flakes were obtained/prepared as in Example 3. Water and water alcohol (ethanol, methanol) mixtures were used to create Rubipy solutions with concentrations in excess of 5 mg/ml. The peptide flakes were soaked in Rubipy solutions for 3 days. Selective "staining" of ridges in the texture, by Rubipy, was observed in optical micrographs.
  • Example 5 EXGPAGPP E ⁇ ; E GSPGPP) E5; EXGVPGPP ⁇ XE ⁇ . Unfolded collagen peptides complexed with EDTA and crystallized. Collagen peptides were dissolved in water at room temperature to obtain concentrations of less than or equal to 100 mg peptide per milliliter of water. Na EDTA solution (pH 8) in water was added to the oligopeptide solution to obtain a charge balance (assuming fully ionized acid groups and base) or an EDTA excess. Alcohol (ethanol, methanol or propanol) was added to the peptide EDTA solution in at least a 2:1 alcohol : aqueous solution excess by volume.
  • Crystalline nuclei appeared immediately and could be filtered from solution after about 1 minute and rapidly grew into lamellae, hundreds of microns in diameter. Crystalline lamllae ( Figure 12) were rinsed with alcohol to remove water. Wet unrinsed crystals were observed to redissolved as the alcohol preferentially evaporated from the liquor surrounding the crystals. Solutions of peptide and EDTA that were allowed to stand for more than 5 minutes after alcohol addition underwent a secondary crystal nucleation event.
  • Collagen peptide is mixed with common buffer salts, and dried at temperatures where the triple helix is stable and where smectic liquid crystalline phases are observed for pure collagen.
  • Collagen peptides (see sequences above) were dissolved in water, and in basic EDTA and tris EDTA buffer solutions. The resulting solutions were placed into wells, as in a multiwell plate or in a multiwell embedding mold. The plate or mold containing the liquid solution was placed into a controlled temperature cooling chamber. Samples were dried over 3-7 days at temperatures ranging from 1-3 ° C. Thick films and flakes were obtained andwere carefully removed from the well plates and embedding molds.
  • Example 7 Collasen-Rubipy layered complex: Collagen peptides were dissolved in water in concentrations from 50 - 100 mg/ml. Rubipy was added to the collagen solutions, h some solutions an excess of peptide (where no excess in either component is defined by a charge balance of fully ionized peptide and fully ionized rubipy) was retained. In some cases an excess of Rubipy was used. In some cases a charge balance was attempted. Solutions were placed into the little eppendorf tubes with rounded bottoms. Solutions were dried in the eppendorf tubes at 1° C, 3 ° C, and 10° C.
  • Control solutions were prepared at the same peptide concentrations and dried at the same temperatures (and in the same containers).
  • a qualitative assessment of the rubipy content in different portions of the dried material was made using the color of the solid.
  • Rubipy is a strongly staining orange compound.
  • White (pure peptide or very low Rubipy content) soft disordered laminated solids and bright to dark orange facetted laminated solids were obtained, often as a mixture from the same contained of dried solution.
  • Dried peptides and Rubipy peptide complexed materials were examined using X-ray techniques and SEM. Tenacing, enhanced beam stability and enhanced contrast were observed for flakes with significant Rubipy content.
  • X-ray data ( Figure 14a,b,c,d) indicate a composite structure with thin crystalline layers of Rubipy interspersed in the peptide.
  • Peptide drying temperature strongly influences the degree of order in the Rubipy diffraction patterns, as well as the peptide signals present.
  • the peptide solutions were placed on a glass microscope slide and covered with a glass coverslip.
  • the glass coverslips on the slides were left unsealed so that slow evaporation of water occurred at the edges of the coverslips.
  • the solutions on glass slides were placed into controlled temperature chambers at 3° C and allowed to stand overnight.
  • the glass slides were removed and observed in the polarizing microscope. Liquid crystalline textures typical of the individual peptide sequences at 3° C were observed. Birefringence in polarized light was greatly enhanced ( Figures 15, 16, and 17) and the textures appeared violet to turquoise blue. White is observed for pure collagen peptide textures ( Figure 15a).
  • Liquid crystalline spheruhtes of collasen peptide and "direct red” chiral dye fused in nonlinear optics) The collagen sequences used were E 5 (GPAGPP) 6 E 5 and E 5 (GAOGPO) 6 E 5 .
  • Collagen solutions were prepared as in Example 8. An excess of Direct red powdered dye was added to the peptide solution. The solution of dye and peptide was placed on glass optical microscopy slides and covered with a glass coverslip. The gap between slide and coverslip was not sealed, allowing slow evaporation of water and concentration of solutions. The covered glass slides were chilled overnight at 3 °C. Spherulitic textures usually associated with smectic C* phase behavior in collagen were observed.
  • Olisopeptides complexed with rare earth oxides The rare earths were chemically incorporated into the oligopeptide materials by mixing lyophilized (freeze dried from an organic solvent solution) oligopeptide powders with pure deionized water and then adding finely powdered rare earth oxide. In order to determine whether ion content could be controlled, slightly different preparation protocols were used to make composites having different expected rare earth content. Some of these mixtures were briefly shaken and allowed to stand for 1 hour to dissolve the oxide. Other mixtures were agitated and heated for one hour and then allowed to stand overnight. After the time allotted to dissolve the oxides had past, solutions with suspended oxide powder were centrifuged at 11,000 RPM for 15 minutes to remove undissolved oxide powder from suspension. The clean supernatant solutions were pipetted into clean silicone wells and allowed to dry at 3° C over a period of several days.
  • Olisopeptides Complexed with Chlorides In order to prepare chloride composites, the rare earths were chemically incorporated into the oligopeptide materials by mixing lyophilized (freeze dried from an organic solvent solution) oligopeptide powders with 0.1 molar solutions of GdCl 3 and DyCl 3 in dilute HCl to obtain the desired ratios of oligopeptide and rare earth. Small ( «1 mg) solid samples were formed from solution by drying the aqueous rare earth ion/oligopeptide solutions in air to obtain thin films at the bottoms of glass vials. In the case of the collagen-like oligopeptide, sequence, the solutions were dried at 3 °C to encourage formation of a rigid collagen-like triple helix.
  • the dried samples were electrically insulating and transparent in the visible region.
  • Polarizing microscopy was used to assess the overall orientation and domain structure in the samples, using a Nikon polarizing optical microscope in transmission mode.
  • Polycrystalline texture data were obtained using a Bruker D8 Discover diffractometer with GADDS, operated using Cu radiation and at a camera length of 8.1 cm. Integrated intensity traces were compared with rare earth salt powder diffraction patterns from the PSF-2 powder diffraction file, to determine whether separate phases of rare earth oxide, chloride, or plausible hydrates or complexes were present.
  • a JEOL 2010 TEM, with a GAT AN energy filter, was used to acquire high resolution TEM images and electron diffraction data.
  • a Quantum Design MPMS SQUID magnetometer with a sensitivity of «10 "5 emu was used to make all magnetic measurements. Magnetic fields to 5.5 T were applied.
  • the mixture was placed back into the oven and allowed to dry overnight. Five cycles of heat drying, rehydrating, shaking and redrying were performed as above. After three cycles the material above the oxide powder (which settles to the bottom of the container due to its high density) started to turn a noticeable bright lemon yellow shade. After 5 cycles the mixture of oxide powder and complexed peptide solution was removed from the oven, shaken again for 2 minutes, sealed and placed in a dust free hood to settle overnight. After the mixture had settled overnight, excess oxide powder was observed in the bottom of the contained and a bright yellow green supernatant solution could be seen above the powder. The bright yellow green supernatant was removed and dried in a separate container.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Nanotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Insects & Arthropods (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Hard Magnetic Materials (AREA)
EP04821785A 2003-12-23 2004-12-23 Metallhaltige nanoschichtverbundwerkstoffe und anwendungen davon Withdrawn EP1730169A2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53232203P 2003-12-23 2003-12-23
PCT/US2004/043745 WO2005101993A2 (en) 2003-12-23 2004-12-23 Metal-containing nanolayered composites, and applications thereof

Publications (1)

Publication Number Publication Date
EP1730169A2 true EP1730169A2 (de) 2006-12-13

Family

ID=35197432

Family Applications (1)

Application Number Title Priority Date Filing Date
EP04821785A Withdrawn EP1730169A2 (de) 2003-12-23 2004-12-23 Metallhaltige nanoschichtverbundwerkstoffe und anwendungen davon

Country Status (5)

Country Link
EP (1) EP1730169A2 (de)
JP (1) JP2007523890A (de)
AU (1) AU2004318682A1 (de)
CA (1) CA2551643A1 (de)
WO (1) WO2005101993A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2462166A2 (de) * 2009-08-03 2012-06-13 Basf Se Verfahren zur abscheidung von dünnen metalloxidschichten
EP2754707A1 (de) * 2013-01-15 2014-07-16 Universite de Rennes 1 Material mit einer Host-Matrix, Seltenerd-Ionen und einem Metallatomcluster als Sensibilisator
WO2015111407A1 (en) 2014-01-22 2015-07-30 Kabushiki Kaisha Toyota Chuo Kenkyusho Rare earth material-binding peptide and use thereof
WO2018047951A1 (ja) * 2016-09-09 2018-03-15 国立大学法人北海道大学 発光材料、インク、及び発光デバイス
KR101889477B1 (ko) * 2016-12-14 2018-08-17 서울대학교산학협력단 펩타이드-무기물 복합 필름 및 그 제조 방법
US10686203B2 (en) 2016-12-14 2020-06-16 Seoul National University R&Db Foundation Peptide-inorganic material composite film and manufacturing method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE191222T1 (de) * 1990-10-02 2000-04-15 Scripps Research Inst Isolierte metallopolypeptide, zusammensetzungen und syntheseverfahren

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2005101993A2 *

Also Published As

Publication number Publication date
WO2005101993A3 (en) 2009-03-19
JP2007523890A (ja) 2007-08-23
AU2004318682A1 (en) 2005-11-03
WO2005101993A9 (en) 2006-06-01
CA2551643A1 (en) 2005-11-03
WO2005101993A2 (en) 2005-11-03

Similar Documents

Publication Publication Date Title
Coronado et al. Polymetallic oxalate-based 2D magnets: soluble molecular precursors for the nanostructuration of magnetic oxides
Jonas et al. Synthesis of a Fullerene [60] Cryptate and Systematic Langmuir‐Blodgett and Thin‐Film Investigations of Amphiphilic Fullerene Derivatives
Bauermann et al. Heterogeneous nucleation of ZnO using gelatin as the organic matrix
Volkringer et al. High-throughput aided synthesis of the porous metal− organic framework-type aluminum pyromellitate, MIL-121, with extra carboxylic acid functionalization
Li et al. Selective in vitro effect of peptides on calcium carbonate crystallization
Tong et al. Control over the crystal phase, shape, size and aggregation of calcium carbonate via a L-aspartic acid inducing process
Clemente‐León et al. Langmuir–Blodgett Films of Single‐Molecule Nanomagnets
Reinholdt et al. Experimental Investigations of Amino Acid-Layered Double Hydroxide Complexes: Glutamate− Hydrotalcite
AU2002365127B2 (en) Self-assembling polymers, and materials fabricated therefrom
Juramy et al. Monitoring crystallization processes in confined porous materials by dynamic nuclear polarization solid-state nuclear magnetic resonance
CA2641785A1 (en) Birefringent metal-containing coordination polymers
EP1730169A2 (de) Metallhaltige nanoschichtverbundwerkstoffe und anwendungen davon
Bette et al. On verdigris, part II: synthesis of the 2-1-5 phase, Cu 3 (CH 3 COO) 4 (OH) 2· 5H 2 O, by long-term crystallisation from aqueous solution at room temperature
US5993541A (en) Process for nucleation of ceramics and product thereof
Gruzdev et al. Piezoactive amino acid derivatives containing fragments of planar-chiral ortho-carboranes
Wagner et al. Switchable electrostatic interactions between gold nanoparticles and coiled coil peptides direct colloid assembly
Tang et al. Compact film fabrication of porous coordination polymer Co 3 [Co (CN) 6] 2 and its reversible vapochromic behavior
Berride et al. Chiral amplification of disodium cromoglycate chromonics induced by a codeine derivative
Rogers et al. Self-assembled fibrillar networks comprised of a naturally-occurring cyclic peptide—LOB3
Pacanowska et al. Thin Films of Solvatomagnetic CN‐Bridged Coordination Polymers: From Micro to Nanoscale
Topor et al. Design of Fe III–Ln III binuclear complexes using compartmental ligands: synthesis, crystal structures, magnetic properties, and ab initio analysis
Nieuwland et al. A structural study of the self-assembly of a palmitoyl peptide amphiphile
Bonazzi et al. Chromonic lyomesophases formed by the self-assembly of the cyclic dinucleotide d (cGpGp)
Langs et al. The crystal structure of calcium copper acetate hexahydrate and its isomorph calcium cadmium acetate hexahydrate
Schmitz et al. Conductive Self-Assembled Monolayers of Paramagnetic {CoII Co 4 III} and {Co 4 II Co 2 III} Coordination Clusters on Gold Surfaces

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20060720

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR LV MK YU

RIN1 Information on inventor provided before grant (corrected)

Inventor name: JIN, HYOUNG-JOON

Inventor name: HUANG, JIA

Inventor name: GUERTIN, ROBERT, P.

Inventor name: HAAS, TERRY, E.

Inventor name: VALLUZZI, REGINA

RIN1 Information on inventor provided before grant (corrected)

Inventor name: JIN, HYOUNG-JOON

Inventor name: HUANG, JIA

Inventor name: GUERTIN, ROBERT, P.

Inventor name: HAAS, TERRY, E.

Inventor name: VALLUZZI, REGINA, DR.

DAX Request for extension of the european patent (deleted)
PUAK Availability of information related to the publication of the international search report

Free format text: ORIGINAL CODE: 0009015

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20090312